EDGAR Filing Documents for 0000921895-14-001993

Form SC 13D - General Statement of Acquisition of Beneficial Ownership:

SEC Accession No. 0000921895-14-001993

Filing Date

2014-09-05

Accepted

2014-09-05 16:15:29

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13D	sc13d07422009_08212014.htm	SC 13D	263906
2	TRADING PLAN AGREEMENT	ex991to13d07422009_08212014.htm	EX-99.1	64970
3	JOINT FILING AGREEMENT	ex992to13d07422009_08212014.htm	EX-99.2	35787
	Complete submission text file	0000921895-14-001993.txt		366204

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611

Business Address ONE SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address 100 NORTH MAIN STREET SUITE 1510 WINSTON-SALEM NC 27101

Business Address 100 NORTH MAIN STREET SUITE 1510 WINSTON-SALEM NC 27101 3364802100

TARGACEPT INC (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82442 | Film No.: 141086147
SIC: 2834 Pharmaceutical Preparations